Skip to main content icon/video/no-internet

The persistence of tuberculosis (TB) as a public health problem is as much a social phenomenon as it is a biological one. As far back as the time of Hippocrates in classical antiquity, TB was commonly referred to as “consumption” because of the characteristic deterioration of the body associated with the disease. Evidence extracted from the mummies of ancient civilizations has revealed that the TB bacillus has plagued human beings for tens of thousands of years. Still in the early 21st century, it is estimated that there are 8 to 12 million new cases of TB worldwide each year. The disease exhibits one of the highest infection rates of all known diseases. The causative agent of TB was discovered by Robert Koch in 1882 to be the rod-shaped bacterium Mycobacterium tuberculosis. The bacteria may infect the lungs and spread to others through sneezing, coughing, spitting, or talking. Notably, only a smaller number of the bacilli need to be inhaled for a person to become infected. Although pulmonary TB is the most well-known variant, TB may also affect the brain, bones, skin and lymph nodes, genitals, and other tissues, which can be eaten away by the bacteria. In addition to weight loss, other symptoms include breathlessness, coughing, fever, malaise, anemia, the disruption of metabolic functions, and psychological disturbances. Pulmonary TB may be identified through sputum (i.e., phlegm from deep inside the chest) microscopy, chest X-rays, or a skin test.

A technician conducts a tuberculin skin test. Recent tuberculosis (TB) outbreaks in cities such as New York and London in the 1980s and 1990s have shown that TB is not simply a disease affecting the developing world.

None

The Etiology of Tuberculosis

The development of TB follows various stages based upon the progression of various defense mechanisms initiated by the human immune response system. Initially, toxic chemicals released by the TB bacteria induce the human body to produce characteristic swellings or lesions at sites where the bacteria become clustered in the infected tissue. During the later stages, the immune system attempts to prevent the spread of TB to other parts of the body by enveloping the lesions in a thick fibrous coating of collagen, while bacteria that do escape the encapsulation are destroyed by immune response agents known as macrophages. The encapsulation eventually forms a hard grain called a granuloma that appears as a small dot on a chest X-ray. The resultant walled-off bacterial clusters can lie dormant in this latent phase for many years. At this stage, the individual is otherwise healthy and noninfectious and is classified as a nonactive case. In roughly 5 to 10 percent of the latent cases, the disease may become activated if the individual's immune system becomes weakened or damaged later in time. During this active stage, the bacteria may overcome the body's defense mechanisms and proliferate in the lungs, where they can be spread more easily to others through respiratory secretions, or be discharged into the circulatory and lymph system, where they can spread to other parts of the body. In terms of developing and implementing effective public health responses to TB, it is important to distinguish between cases that are the result of recent transmission (i.e., secondary cases) and those resulting from reactivation of old infections, especially since the original site of infection may be very distant from where the latent case currently resides, as well as very distant in the past.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading